EXANE DERIVATIVES - QIAGEN NV ownership

QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 217 filers reported holding QIAGEN NV in Q3 2017. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of QIAGEN NV
ValueSharesWeighting
Q2 2022$772,584,00016,639
+11.8%
0.44%
Q1 2022$014,886
-47.9%
0.00%
Q4 2021$0
-100.0%
28,548
-47.3%
0.00%
Q3 2021$1,00054,157
+53.3%
0.00%
Q2 2021$0
-100.0%
35,328
-9.7%
0.00%
-100.0%
Q1 2021$1,091,671,000
-12.4%
39,103
-8.4%
0.31%
-15.0%
Q4 2020$1,246,815,000
-40.5%
42,673
-43.2%
0.37%
-39.4%
Q3 2020$2,093,753,000
+451.7%
75,105
+427.6%
0.61%
+500.0%
Q2 2020$379,537,000
+1046.4%
14,234
+344.8%
0.10%
+1583.3%
Q3 2018$33,107,000
-70.5%
3,200
-11.1%
0.01%
-66.7%
Q2 2018$112,056,000
+635.8%
3,600
+599.0%
0.02%
+500.0%
Q1 2018$15,229,000
-91.7%
515
-89.9%
0.00%
-90.6%
Q4 2017$183,193,000
+135.5%
5,105
+297.3%
0.03%
+113.3%
Q3 2017$77,790,000
-94.5%
1,285
-97.0%
0.02%
-95.0%
Q2 2017$1,405,289,000
-41.8%
42,563
-48.7%
0.30%
-44.7%
Q1 2017$2,412,966,00082,9440.55%
Other shareholders
QIAGEN NV shareholders Q3 2017
NameSharesValueWeighting ↓
SYCOMORE ASSET MANAGEMENT 2,368,913$86,182,00040.56%
Hardman Johnston Global Advisors LLC 4,407,084$151,824,0007.86%
Tikvah Management LLC 442,942$15,259,0005.41%
EDMOND DE ROTHSCHILD HOLDING S.A. 2,594,057$88,155,0003.09%
Opus Point Partners Management, LLC 31,463$1,084,0002.39%
SECTOR GAMMA AS 407,406$14,035,0002.36%
SANDLER CAPITAL MANAGEMENT 804,049$27,699,0002.35%
Sivik Global Healthcare LLC 110,800$3,817,0002.06%
Acorn Advisory Capital L.P. 9,800$338,0001.21%
Eversept Partners, LP 55,300$1,905,0851.03%
View complete list of QIAGEN NV shareholders